Potentialities of adjuvant endocrine therapy for breast cancer (Part II)

Potentialities of adjuvant endocrine therapy for breast cancer (Part II)

Potentialities of adjuvant endocrine therapy for breast cancer (Part II)

Saved in:

Bibliographic Details
Main Authors:	N. Yu. Dobrovolskaya, E. K. Vvoznyi, Yu. M. Bychkov
Format:	Article
Language:	Russian
Published:	ABV-press 2014-09-01
Series:	Опухоли женской репродуктивной системы
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/378
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adjuvant endocrinotherapy of breast cancer (part I)
by: N. Yu. Dobrovolskaya, et al.
Published: (2014-09-01)

Side-effects in women treated with adjuvant endocrine therapy for breast cancer
by: L.M. Rademaker, et al.
Published: (2025-04-01)

Influencing Factors of Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients: A Meta‐Analysis
by: Xiaofeng Wang, et al.
Published: (2025-06-01)

Vitamin D Level in Postmenopausal Breast Cancer Patients Before and After Adjuvant Chemotherapy and Endocrine Therapy
by: Barrak F. Al Obeidy, et al.
Published: (2024-12-01)

Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer
by: Joyce O'Shaughnessy, et al.
Published: (2025-06-01)

Cardiovascular risks associated with adjuvant endocrine therapy in women with breast cancer: a population-based cohort study
by: Iokfai Cheang, et al.
Published: (2025-07-01)

Early prediction of menopausal status after chemotherapy in women with early breast cancer in order to optimize adjuvant endocrine therapy
by: Charissa van Zwol-Janssens, et al.
Published: (2025-10-01)

Escalation of adjuvant endocrine therapy for early hormone-dependent HER2-negative breast cancer: to whom, when and why?
by: I. V. Kolyadina
Published: (2024-05-01)

Correlation Between Adverse Reactions in Adjuvant Endocrine Therapy and Cytokines for Early-Stage Luminal-Type Breast Cancer Patients
by: Xiaojuan ZHENG, et al.
Published: (2025-07-01)

American society of clinical oncology update on the role of bisphosphonates and bone health issues in women with breast cancer Part II. Bisphosphonates in the adjuvant therapy of breast cancer
by: I. V. Vysotskaya
Published: (2014-09-01)

Current feasibility of endocrine therapy for breast cancer
by: I. V. Vysotskaya
Published: (2014-07-01)

Adjuvant therapy for early breast cancer
by: I. V. Vysotskaya
Published: (2014-07-01)

PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER
by: R. I. Yagudina, et al.
Published: (2015-03-01)

NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER
by: V. F. Semiglazov, et al.
Published: (2018-07-01)

A review of endocrine therapy for hormone-dependent breast cancer
by: A. N. Useinova, et al.
Published: (2024-07-01)

Taxanes in adjuvant and neoadjuvant therapy for breast cancer
by: S. V. Limareva
Published: (2014-08-01)

Adherence to Adjuvant Endocrine Therapy in Patients With Nonmetastatic Estrogen Receptor–Positive Breast Cancer: A Comprehensive Brazilian Real-World Data Study
by: Daniele Assad-Suzuki, et al.
Published: (2025-04-01)

Adjuvant endocrine treatment strategies for non-metastatic breast cancer: a network meta-analysisResearch in context
by: Andri Papakonstantinou, et al.
Published: (2025-03-01)

The potential of chimeric antigen receptor -T cell therapy for endocrine cancer
by: Ruonan Yu, et al.
Published: (2025-04-01)

The role of Taxotere in adjuvant therapy for early breast cancer
by: I. V. Kolyadina, et al.
Published: (2014-07-01)

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2– breast cancer (LEADER)
by: Laura M. Spring, et al.
Published: (2025-01-01)

Adjuvant hormonal therapy in premenopausal women with breast cancer
by: Lillian Smyth, et al.
Published: (2015-01-01)

Access to and Utilization of Endocrine Therapy Among Breast Cancer Survivors in Botswana
by: James R. Wester, et al.
Published: (2024-12-01)

Choice of adjuvant drug therapy on the basis of the molecular classification of breast cancer
by: N. S. Besova
Published: (2014-07-01)

Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancer
by: Jason I Griffiths, et al.
Published: (2025-05-01)

Escalation and De-Escalation Strategies for Endocrine Therapy in Early-Stage Breast Cancer
by: Al-Batsh T, et al.
Published: (2025-03-01)

EFFICACY OF HYPOFRACTIONATED ADJUVANT RADIATION THERAPY IN PATIENTS WITH OPERABLE BREAST CANCER
by: G. V. Afonin, et al.
Published: (2018-11-01)

Multimodal recurrence risk prediction model for HR+/HER2- early breast cancer following adjuvant chemo-endocrine therapy: integrating pathology image and clinicalpathological features
by: Xiaoyan Wu, et al.
Published: (2025-03-01)

Neoadjuvant Chemo-Endocrine Therapy for Hormone Receptor Positive Breast Cancer: A Meta-Analysis
by: Zhen-Yu Li, et al.
Published: (2023-04-01)

Individual approach to choosing an appropriate regimen of adjuvant hormone therapy in patients with early-stage breast cancer
by: E. M. Slonimskaya, et al.
Published: (2018-10-01)

A community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors (PACHA): protocol for a pilot cluster-randomized controlled trial
by: Julie Lapointe, et al.
Published: (2025-07-01)

ENDOCRINE TREATMENT OPTIONS FOR ADVANCED BREAST CANCER — THE ROLE OF FULVESTRANT
by: J.F.R. Robertson, et al.
Published: (2014-09-01)

LONG-TERM OUTCOMES IN BREAST CANCER PATIENTS AFTER COMPLEX TREATMENT WITH ADJUVANT RADIATION THERAPY
by: K. A. Simonov, et al.
Published: (2016-02-01)

ACCELERATED REGIMENS OF ADJUVANT RADIOTHERAPY IN THE TREATMENT OF BREAST CANCER
by: G. V. Afonin, et al.
Published: (2017-09-01)

Breast cancer in young patients. Peculiarities of prognosis and adjuvant hormone therapy (a literature review)
by: D. N. Kravchenko, et al.
Published: (2018-10-01)

Editorial: Endocrine aspects of gynaecological cancers, volume II
by: Stefano Palomba, et al.
Published: (2025-07-01)

ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
by: Aritro Nath, et al.
Published: (2022-06-01)

The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer
by: Zheqi Li, et al.
Published: (2024-12-01)

Comparative Efficacy of Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, and Neoadjuvant Chemo-Endocrine Therapy in Estrogen Receptor–Positive Breast Cancer Patients: A Meta-Analysis
by: Yi Yuan, et al.
Published: (2025-01-01)

Zoledronic acid as an adjuvant therapy in patients with breast cancer: a systematic review and meta-analysis.
by: Wei-Wei Huang, et al.
Published: (2012-01-01)